Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.30
Delayed Data
As of Jun 26
 -0.05 / -3.70%
Today’s Change
1.13
Today|||52-Week Range
4.62
-53.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues33.7M28.1M61.2M0.00
 
 
 
 
Cost of Goods Sold1.9M1.0M3.3M0.00
 
 
 
 
Depreciation And Amortization1.5M2.2M1.0M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income30.3M24.9M56.9M-1.2M
 
 
 
 
 
General Expenses60.2M47.9M75.3M26.1M
 
 
 
 
 
Research And Development41.0M32.1M52.2M21.6M
 
 
 
 
 
Total Operating Expenses63.5M51.1M79.7M27.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.9M-23.1M-18.4M-27.2M
 
 
 
 
 
Extraordinary Charge-14.6M-15.4M-7.8M0.00
 
 
 
 
Interest Expense On Debt6.6M0.007.1M2.0M
 
 
 
 
Other Expenses-64.0K385.0K-286.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-51.0M-30.3M-33.6M-29.2M
 
 
 
 
 
Minority Interest-208.0K-207.0K-1.2M-467.0K
 
 
 
 
 
Discontinued Operations0.000.000.00-947.0K
 
 
Net Income-50.8M-30.1M-32.4M-29.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.2M129.2M129.8M130.6M
 
 
 
 
 
Shares To Calculate EPS Diluted126.2M129.2M129.8M130.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.23-$0.25-$0.23
 
 
 
 
 
EPS Diluted-$0.40-$0.23-$0.25-$0.23